Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese Adults
Condition:   Influenza, HumanIntervention:   Drug: ZanamivirSponsor:   GlaxoSmithKlineNot yet recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2015 Category: Research Source Type: clinical trials

Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese Adults
Condition:   Influenza, HumanIntervention:   Drug: ZanamivirSponsor:   GlaxoSmithKlineNot yet recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2015 Category: Research Source Type: clinical trials

Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese Adults
Condition:   Influenza, HumanIntervention:   Drug: ZanamivirSponsor:   GlaxoSmithKlineRecruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2015 Category: Research Source Type: clinical trials

A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection
Condition:   Influenza, HumanIntervention:   Drug: Intravenous (IV) zanamivirSponsors:   GlaxoSmithKline;   GlaxoSmithKlineRecruiting - verified October 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2011 Category: Research Source Type: clinical trials

A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection
Condition:   Influenza, HumanIntervention:   Drug: Intravenous (IV) zanamivirSponsors:   GlaxoSmithKline;   GlaxoSmithKlineActive, not recruiting - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2011 Category: Research Source Type: clinical trials

A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection
Condition:   Influenza, HumanIntervention:   Drug: Intravenous (IV) zanamivirSponsors:   GlaxoSmithKline;   GlaxoSmithKlineCompleted - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2011 Category: Research Source Type: clinical trials

A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection
Condition:   Influenza, HumanIntervention:   Drug: Intravenous (IV) zanamivirSponsor:   GlaxoSmithKlineCompleted - verified June 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2011 Category: Research Source Type: clinical trials

A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection
Condition:   Influenza, HumanIntervention:   Drug: Intravenous (IV) zanamivirSponsor:   GlaxoSmithKlineCompleted - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2011 Category: Research Source Type: clinical trials

A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza
Condition:   Influenza, HumanInterventions:   Drug: 300mg intravenous (IV) zanamivir and oral oseltamivir placebo;   Drug: 600mg intravenous (IV) zanamivir and oral oseltamivir placebo;   Drug: 75mg oral oseltamivir and intravenous zanamivir placeboSponsor:   GlaxoSmithKlineRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 28, 2010 Category: Research Source Type: clinical trials

A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza
Condition:   Influenza, HumanInterventions:   Drug: 300mg intravenous (IV) zanamivir and oral oseltamivir placebo;   Drug: 600mg intravenous (IV) zanamivir and oral oseltamivir placebo;   Drug: 75mg oral oseltamivir and intravenous zanamivir placeboSponsor:   GlaxoSmithKlineRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 28, 2010 Category: Research Source Type: clinical trials

A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza
Condition:   Influenza, HumanInterventions:   Drug: 300mg intravenous (IV) zanamivir and oral oseltamivir placebo;   Drug: 600mg intravenous (IV) zanamivir and oral oseltamivir placebo;   Drug: 75mg oral oseltamivir and intravenous zanamivir placeboSponsor:   GlaxoSmithKlineRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 28, 2010 Category: Research Source Type: clinical trials

A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza
Condition:   Influenza, HumanInterventions:   Drug: 300mg intravenous (IV) zanamivir and oral oseltamivir placebo;   Drug: 600mg intravenous (IV) zanamivir and oral oseltamivir placebo;   Drug: 75mg oral oseltamivir and intravenous zanamivir placeboSponsor:   GlaxoSmithKlineRecruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 28, 2010 Category: Research Source Type: clinical trials

Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Condition:   Influenza, HumanIntervention:   Drug: zanamivir aqueous solutionSponsor:   GlaxoSmithKlineRecruiting - verified August 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2009 Category: Research Source Type: clinical trials